Methylene blue is gaining momentum. Patients are hearing claims about improvements for brain fog, focus, memory, and mitochondrial health. But how much of that is backed by evidence? 

In this episode, NatMed editors Jeff Langford, Andrea Stafford, and Kelly Daniels break down what methylene blue is, what the evidence shows, and why safety may be a bigger concern than many patients realize.

Questions we answer:

• What is methylene blue, and why is it trending?
• Does it actually help with brain fog, focus, or memory?
• What are key safety risks and drug interactions clinicians should know about?
• Which patients should avoid methylene blue entirely? 

We also cover:

• Why methylene blue is not a natural supplement
• Product quality and regulatory concerns
• SSRIs, serotonin syndrome, and other interaction risks
• How to counsel patients when the hype exceeds the evidence 

🏷️ Our listeners can get 10% off a new or upgraded subscription with code natmed1026 at checkout. 

******

NatMed / TRC Healthcare Editor Hosts: 

• Jeff Langford PharmD, BCPS, BCCP (Managing Clinical Editor)
• Andrea Stafford, PharmD (Assistant Editor)
• Kelly Daniels, BA (News Editor & Associate Content Manager)

******

CE Information:

This podcast is sourced from the NatMed August Newsletter. To claim CE credit, subscribers should read the newsletter and click “Take the CE Quiz” link to take the quiz. 

Claim Credit

******

The clinical resources mentioned during the podcast are part of a subscription to NatMed: 

• 🌱 NatMed Pro
• 💊 TRC Healthcare
• Newsletter
• Infographic
• Monograph: Methylene Blue

Send us Fan Mail

Email us: ContactUs@trchealthcare.com 

The content of this podcast is not intended to be a substitute for professional medical advice, diagnosis, or treatment.

Natural Medicines: Evidence in Practice is a production of TRC Healthcare.